[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Thoreux et al., 2007 - Google Patents

Functional foods, mucosal immunity and aging: effect of probiotics on intestinal immunity in young and old rats

Thoreux et al., 2007

View PDF
Document ID
16191960424800916270
Author
Thoreux K
Owen R
Schmucker D
Publication year
Publication venue
Communicating Current Research and Educational Topics and Trends in Applied Microbiology

External Links

Snippet

The elderly are characterized by immunosenescence which is accompanied by an increase in the incidence of infectious diseases, especially in the intestinal tract. There is evidence suggesting that certain probiotic organisms have immunomodulatory properties. Therefore …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23Y2220/00—Lactobacillus
    • A23Y2220/73—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens

Similar Documents

Publication Publication Date Title
Olivares et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination
Rautava et al. New therapeutic strategy for combating the increasing burden of allergic disease: probiotics—a Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report
Hosono et al. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells
Galdeano et al. Impact of a probiotic fermented milk in the gut ecosystem and in the systemic immunity using a non-severe protein-energy-malnutrition model in mice
Cross Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens
Tannock Studies of the intestinal microflora: a prerequisite for the development of probiotics
Mercenier et al. Probiotics as biotherapeutic agents: present knowledge and future prospects
Fuller Probiotics 2: applications and practical aspects
JP4706016B2 (en) Bifidobacterium in the treatment of inflammatory diseases
Fooks et al. Probiotics as modulators of the gut flora
Griffiths et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice
Mercenier et al. Probiotics as biotherapeutic agents: present knowledge and future prospects
Casas et al. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals
Żukiewicz-Sobczak et al. Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases
Vinderola et al. Milk fermented by Lactobacillus helveticus R389 and its non-bacterial fraction confer enhanced protection against Salmonella enteritidis serovar Typhimurium infection in mice
TW202214839A (en) Lactobacillus paracasei 207-27 and use thereof
Núñez et al. Evaluation of immune response, microbiota, and blood markers after probiotic bacteria administration in obese mice induced by a high-fat diet
US10052354B2 (en) Anti-allergic composition
Gackowska et al. Combined effect of different lactic acid bacteria strains on the mode of cytokines pattern expression in human peripheral blood mononuclear cells
Bansal et al. Probiotics: from functional foods to pharmaceutical products
Jain et al. Probiotic dahi containing Lactobacillus casei protects against Salmonella enteritidis infection and modulates immune response in mice
JP2006506371A (en) Method for improving immune function in mammals using a Lactobacillus reuteri strain
Nigam Probiotics as functional foods in enhancing gut immunity
Thoreux et al. Functional foods, mucosal immunity and aging: effect of probiotics on intestinal immunity in young and old rats
Viaşu-Bolocan et al. Probiotics and their immunomodulatory potential